FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

50627005: Labetalol hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
84354015 Labetalol hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
84355019 Ibidomide hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
788436017 Labetalol hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2703971000005111 Labetalolhydrochlorid da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Labetalol hydrochloride Is a Product containing labetalol (medicinal product) false Inferred relationship Some
Labetalol hydrochloride Is a Labetalol (substance) false Inferred relationship Some
Labetalol hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Beta adrenergic receptor antagonist (disposition) true Inferred relationship Some
Labetalol hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Alpha-1 adrenergic receptor antagonist (disposition) true Inferred relationship Some
Labetalol hydrochloride Is a ikke-selektiv beta-blokker false Inferred relationship Some
Labetalol hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Labetalol (substance) true Inferred relationship Some
Labetalol hydrochloride Is a Alpha-1 adrenergic receptor antagonist true Inferred relationship Some
Labetalol hydrochloride Is a Alpha adrenergic receptor antagonist false Inferred relationship Some
Labetalol hydrochloride Is a Ethanolamine and/or ethanolamine derivative (substance) true Inferred relationship Some
Labetalol hydrochloride Is a Vasodilator (substance) true Inferred relationship Some
Labetalol hydrochloride Is a Substance with beta adrenergic receptor antagonist mechanism of action (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Labetalol hydrochloride 100 mg oral tablet Is a False Labetalol hydrochloride Inferred relationship Some
Labetalol hydrochloride 200 mg oral tablet Is a False Labetalol hydrochloride Inferred relationship Some
Labetalol hydrochloride 50 mg oral tablet Is a False Labetalol hydrochloride Inferred relationship Some
labetalolhydrochlorid 5 mg/ml injektionsvæske, opløsning, 20 ml ampul Is a False Labetalol hydrochloride Inferred relationship Some
Labetalol hydrochloride 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
Labetalol hydrochloride 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
Labetalol hydrochloride 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
Labetalol hydrochloride 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
labetalolhydrochlorid 5 mg/ml injektionsvæske, opløsning, 20 ml ampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
labetalolhydrochlorid 5 mg/ml injektionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
Labetalol hydrochloride 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
Labetalol hydrochloride 50mg/10mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
hydrochlorthiazid 25 mg + labetalolhydrochlorid 200 mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
labetalolhydrochlorid 5 mg/ml injektionsvæske, opløsning, 20 ml hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
labetalolhydrochlorid 5 mg/ml injektionsvæske, opløsning, 40 ml hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
labetalolhydrochlorid 5 mg/ml injektionsvæske, opløsning, 4 ml hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
labetalolhydrochlorid 50 mg/10 ml i fyldt injektionssprøjte The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some
Labetalol hydrochloride 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 100 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 200 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 400 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 300 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Labetalol hydrochloride Inferred relationship Some 1
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Labetalol hydrochloride Inferred relationship Some 1
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 100 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 200 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 400 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 300 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Labetalol hydrochloride Inferred relationship Some 1
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Labetalol hydrochloride Inferred relationship Some 1
Product containing precisely labetalol hydrochloride 100 milligram/20 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Labetalol hydrochloride Inferred relationship Some 1
Product containing precisely labetalol hydrochloride 100 milligram/20 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 5 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Labetalol hydrochloride Inferred relationship Some 1
Labetalol hydrochloride 5 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Labetalol hydrochloride Inferred relationship Some 1
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Labetalol hydrochloride Inferred relationship Some 2
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Labetalol hydrochloride Inferred relationship Some 2

Reference Sets

GB English

US English

Back to Start